HOME > Show > 2017 Show > MI_2016_Christopher_R_Anzalone_-_Arrowhead_Pharmaceuticals

MI_2016_Christopher_R_Anzalone_-_Arrowhead_Pharmaceuticals

By Andreas Ettl 02 May 2016

0 mins. to read

Master Investor 2016 Presentation – Christopher R. Anzalone – Arrowhead Pharmaceuticals

Mellon on the Markets – Christmas Letter 2024

Every year is interesting, but this one has been especially so. Lots of geopolitics, the…
Introducing the QuotedData Investors’ Choice Awards

Every year, the industry hands out awards to the managers and trusts that it thinks are doing the…
Rachel Reeves’ Budget Announcement: What Rising Capital Gains Tax Means for Investors

Following Shadow Chancellor Rachel Reeves' announcement, speculation over the upcoming budget has…